Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat

Hypertension

Volumn 28, Issue 6, 1996, Pages 995-1004

  Marttila, Minna ^a   Vuolteenaho, Olli ^a   Ganten, Detlev ^b   Nakao, Kazuwa ^c   Ruskoaho, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

gene expression; hormones; natriuretic peptides; rats, transgenic; renin; renin angiotensin system

Indexed keywords

ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; MESSENGER RNA; PEPTIDE; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOT HYBRIDIZATION; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; NORTHERN BLOTTING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SECRETION; TRANSGENIC ANIMAL;

EID: 0029808569     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.6.995     Document Type: Article

References (45)

1. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse ren-2 gene. Nature. 1990;334:541-544.
2. Ganten D, Lindpaintner K, Ganten U, Peters J, Zimmerman F, Bader M, Mullins J. Transgenic rats: new animal models in hypertension research. Hypertension. 1991;17:843-855.
3. Paul M, Wagner J, Hoffmann S, Urata H, Ganten D. Transgenic rats: new experimental models for the study of candidate genes in hypertension research. Annu Rev Physiol. 1994;56:811-829.
4. Bachmann S, Peters J, Engler E, Ganten D, Mullins J. Transgenic rats carrying the mouse renin gene: morphological characterization of a low-renin hypertension model. Kidney Int. 1992;41:24-36.
5. Springate JE, Feld LG, Ganten D. Renal function in hypertensive rats transgenic for mouse renin gene. Am J Physiol. 1993;266:F731-F737.
6. d renin gene in transgenic hypertensive rats, TGR(mREN2)27. Am J Physiol. 1993;265:E699-E707.
7. Tokita Y, Franco-Saenz R, Mulrow PJ, Ganten D. Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mREN2)27. Endocrinology. 1994;134:253-257.
8. Lee MA, Böhm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rats. Hypertension. 1995;25(part 1):570-580.
9. Bader M, Zhao Y, Sander M, Lee MA, Bachmann J, Böhm M, Djavidani B, Peters J, Mullins JJ, Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension. 1992;19:681-686.
10. Moriguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994;266:R1273-R1279.
11. Böhm M, Lee MA, Kreutz R, Kim S, Schinke M, Djavidani B, Wagner J, Kaling M, Wienen W, Bader M, Ganten D. Angiotensin II receptor blockade in TGR(mREN-2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions. J Hypertens. 1995;13:891-899.
12. Lang CC, Choy AM, Struthers AD. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci. 1992;83:519-527.
13. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I: natriuretic peptides. J Hypertens. 1992;10:907-912.
14. Ruskoaho H. Atrial natriuretic peptide: synthesis, metabolism and release. Pharmacol Rev. 1992;44:479-602.
15. Ogawa Y, Nakao K. Brain natriuretic peptide as a cardiac hormone in cardiovascular disorders. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press Ltd; 1995:833-840.
16. Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H, Saito Y, Suga S-I, Jougasaki M, Imura H. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats: the ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res. 1991;69:491-500.
17. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
18. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990;70: 229-255.
19. Stevens TL, Wei CM, Aarhus LL, Heublein DM, Kinoshita M, Matsuda Y, Burnett JC. Modulation of endogenous atrial natriuretic peptide by a receptor inhibitor. Hypertension. 1994;23:613-618.
20. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995;267:679-681.
21. Stevens TL, Burnett JC, Kinoshita M, Matsuda Y, Redfield MM. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J Clin Invest. 1995;95: 1101-1108.
22. Ruskoaho H, Kinnunen P, Taskinen T, Vuolteenaho O, Leppäluoto J, Takala TES. Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium: effects of exercise. Circulation. 1989;80:390-400.
23. Vuolteenaho O, Arjamaa O, Ling N. Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids. Biochem Biophys Res Commun. 1985;129:82-88.
24. Magga J, Marttila M, Mäntymaa P, Vuolteenaho O, Ruskoaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology. 1994; 134:2505-2515.
25. Flynn TG, Davies PL, Kennedy BP, de Bold ML, de Bold AJ. Alignment of rat cardionatrin sequences with the preprocardionatrin sequence from complementary DNA. Science. 1985;228:323-325.
26. Villarreal FJ, MacKenna DA, Omens JH, Dillmann WH. Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension. 1995;25:98-104.
27. Ruskoaho H, Leppaluoto J. Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothalamus, and plasma of genetically hypertensive rats. Circ Res. 1988;62:384-394.
28. Chien K, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiological response. FASEB J. 1991;5: 3037-3046.
29. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 1993;55:55-75.
30. Lattion AL, Michel JB, Amauld E, Corvol P, Soubrier F. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol. 1986;251:H890-H896.
31. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system: an appraisal of present experimental and clinical evidence. Circ Res. 1991;68:905-921.
32. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res. 1993;73:413-423.
33. Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL. Angiotensin and bradykinin peptides in the TGR(mREN-2)27 rat. Hypertension. 1995;25:1014-1020.
34. Sander M, Bader M, Djavidani B, Maser-Gluth C, Vecsei P, Mullins J, Ganten D, Peters J. The role of the adrenal gland in hypertensive transgenic rat TGR(mREN-2)27. Endocrinology. 1992;131: 807-814.
35. Peters J, Munter K, Bader M, Hackenthal E, Mullins JJ, Ganten D. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium. J Clin Invest. 1992;91:251-257.
36. Kohno M, Horio T, Yoshiyama M, Takeda T. Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension. Hypertension. 1992;19: 206-211.
37. Dagnino L, Lavigne JP, Nemer M. Increased transcripts for B-type natriuretic peptide in spontaneously hypertensive rats: qualitative polymerase chain reaction for atrial and brain natriuretic peptide transcripts. Hypertension. 1992;20:690-700.
38. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 1993;132:1961-1970.
39. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CGA, Edwards WD, Schaff HV, Burnett JC. Natriuretic peptide system in human heart failure. Circulation. 1993;88:1004-1009.
40. Tamura N, Ogawa Y, Itoh H, Arai H, Suga S, Nakagawa O, Komatsu Y, Kishimoto I, Takaya K, Yoshimasa T, Shiono S, Nakao K. Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. J Clin Invest. 1994;94:1059-1068.
41. Mäntymaa P, Vuolteenaho O, Marttila M, Ruskoaho H. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology. 1993; 133:1470-1473.
42. Thibault G, Charbonneau C, Bilodeau J, Schiffrin EL, Garcia R. Rat brain natriuretic peptide is localized in atrial granules and released into the circulation. Am J Physiol. 1992;263:R301-R309.
43. Hilgers KF, Peters J, Veelken R, Sommer M, Rupprecht G, Ganten D, Luft FC, Mann FE. Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene. Hypertension. 1992;19:687-691.
44. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ Hypertension in the transgenic rat TGR(mREN-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension. 1994;23:422-427.
45. Lo M, Medeiros IA, Mullins JJ, Ganten D, Barres C, Cerutti C, Vincent M, Sassard J. High blood pressure maintenance in transgenic mRen-2 vs. Lyon genetically hypertensive rats. Am J Physiol. 1993; 265:R180-R186.